Posted by Michael Wonder on 05 Feb 2022
CADTH establishes new post-market drug evaluation program
4 February 2022 - CADTH is pleased to announce it is expanding its expertise in the management of pharmaceuticals in Canada with the creation of a new post-market drug evaluation program.
The post-market drug evaluation program will be responsible for launching and co-ordinating a network that leverages Canadian expertise in applied drug research, methodology, and data analysis.
The program’s aim will be to deliver timely and credible evidence on the post-market safety and effectiveness of drugs approved for use in Canada.
